Effectiveness of Non-invasive Neuromodulation for Intestinal Transit in Healthy Subjects - Trial NCT06294457
Access comprehensive clinical trial information for NCT06294457 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad Europea de Madrid and is currently Not yet recruiting. The study focuses on Constipation. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universidad Europea de Madrid
Timeline & Enrollment
N/A
Mar 01, 2024
Jun 01, 2024
Primary Outcome
Quality of life by constipation (CVE-20)
Summary
Objectives
 
 Main objective:
 
 Assess the effectiveness of non-invasive neuromodulation treatment (NESA) for the management
 of constipation in patients without diagnosed pathology in Spain
 
 Secondary objectives:
 
 Evaluate the improvement in sleep quality Analyze the improvement in blood pressure quality
 Measure the improvement in cortisol quality Determine if there is an improvement in heart
 rate
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06294457
Device Trial